EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CS Medica AS's Enterprise Value is €2.34 Mil.
CS Medica AS's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €-1.03 Mil. Therefore, CS Medica AS's EV-to-FCF for today is -2.26.
The historical rank and industry rank for CS Medica AS's EV-to-FCF or its related term are showing as below:
STU:8G8'
s EV-to-FCF Range Over the Past 10 Years
Min: -36.45 Med: -6.59 Max: -2.48
Current: -2.89
During the past 6 years, the highest EV-to-FCF of CS Medica AS was -2.48. The lowest was -36.45. And the median was -6.59.
STU:8G8's EV-to-FCF is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 27.14
vs STU:8G8: -2.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for CS Medica AS's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CS Medica AS's EV-to-FCF
For the Medical Devices subindustry, CS Medica AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CS Medica AS's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CS Medica AS's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where CS Medica AS's EV-to-FCF falls into.
CS Medica AS's current Enterprise Value is €2.34 Mil.
CS Medica AS's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CS Medica AS (STU:8G8) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CS Medica AS's PE Ratio (TTM) for today is calculated as:
CS Medica AS's share price for today is €0.484.
CS Medica AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.101.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CS Medica AS EV-to-FCF Related Terms
Thank you for viewing the detailed overview of CS Medica AS's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:8G8 has been successfully added to your 